Table 3 AFs attributable (95% eCI) to non-optimal temperatures by development level
Subgroups | Total | Cold | Heat | |||
|---|---|---|---|---|---|---|
HDRs | LDRs | HDRs | LDRs | HDRs | LDRs | |
Nationwide | 8.9(8.3–9.5) | 12.2(11.0–13.5) | 8.5(7.9–9.1) | 10.4(9.3–11.4) | 0.4(0.3–0.5) | 1.9(1.1–2.6) |
Northern China | 7.3(4.8–9.7) | 14.9(11.7–18.7) | 4.0(2.3–5.7) | 8.0(6.0–9.9) | 3.3(1.4–5.1) | 6.9(4.1–10.3) |
Southern China | 9.8(8.9–10.8) | 12.5(11.1–13.9) | 9.5(8.6–10.4) | 10.7(9.4–11.8) | 0.3(0.2–0.4) | 1.8(1.0–2.6) |
Age 0–64 | 6.5(3.7–9.1) | 9.4(7.7–11.2) | 5.3(3.7–6.7) | 7.5(6.0–8.9) | 1.3(− 1.0–3.4) | 2.0(1.0–3.0) |
Age65+ | 13.3(12.1–14.6) | 16.2(15.0–17.4) | 12.6(11.5–13.9) | 14.4(13.4–15.4) | 0.7(0.4–0.9) | 1.8(1.0–2.6) |
Males | 10.2(8.7–11.7) | 11.7(10.2–13.2) | 9.6(8.2–11.0) | 10.1(9.2–11.0) | 0.6(0.2–1.0) | 1.6(0.5–2.8) |
Females | 8.2(7.4–9.0) | 11.1(9.6–12.6) | 7.7(6.8–8.5) | 9.6(8.3–10.9) | 0.6(0.5–0.6) | 1.5(0.7–2.5) |
Cardiovascular diseases | 11.3(9.7–12.9) | 14.6(12.8–16.5) | 9.8(8.2–11.2) | 12.4(11.5–13.2) | 1.6(0.9–2.2) | 2.3(0.7–3.8) |
Respiratory diseases | 13.3(10.2–16.4) | 13.9(10.1–17.3) | 11.2(9.0–13.4) | 8.0(6.9–9.0) | 2.1(− 0.4–4.6) | 5.9(2.4–9.2) |